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Abstract
Small G-proteins, are a family of hydrolase enzymes that can bind and hydrolyze guanosine triphosphate (GTP).
They are a type of G-protein found in the cytosol that are homologous to the alpha subunit of heterotrimeric G-
proteins, but unlike the alpha subunit of G proteins, a small GTPase can function independently as a hydrolase
enzyme to bind to and hydrolyze a guanosine triphosphate (GTP) to form guanosine diphosphate (GDP). The
best-known members are the Ras GTPases and hence they are sometimes called Ras subfamily GTPases.
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This is a citation summary for 3.6.5.2 Small monomeric GTPases in the Guide to Pharmacology database
(GtoPdb). It exists purely as an adjunct to the database to facilitate the recognition of citations to and from the
database by citation analyzers. Readers will almost certainly want to visit the relevant sections of the database
which are given here under database links.
GtoPdb is an expert-driven guide to pharmacological targets and the substances that act on them. GtoPdb is a
reference work which is most usefully represented as an on-line database. As in any publication this work
should be appropriately cited, and the papers it cites should also be recognized. This document provides a
citation for the relevant parts of the database, and also provides a reference list for the research cited by those
parts.
Please note that the database version for the citations given in GtoPdb are to the most recent preceding version
in which the family or its subfamilies and targets were substantially changed. The links below are to the current
version. If you need to consult the cited version, rather than the most recent version, please contact the GtoPdb
curators.
Database links
3.6.5.2 Small monomeric GTPases
http://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=896
    RAS subfamily
    http://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=897
    Introduction to RAS subfamily
    http://www.guidetopharmacology.org/GRAC/FamilyIntroductionForward?familyId=897
        Enzymes
                HRAS
1
                http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2822
                NRAS
                http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2823
                KRAS
                http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2824
    RAB subfamily
    http://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=938
        Enzymes
                RAB27A, member RAS oncogene family
                http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2916
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